Description
Book SynopsisTable of ContentsSection 1: Introduction
1. History of Insulin
2. Insulin Use in India's Challenges
Section 2: Basic Physiology and Pharmacology
3. Physiology of Insulin Secretion
4. Taxonomy of Insulin
5. Insulin Analogs
Section 3: Insulin Guidelines
6. Choosing an Insulin Regimen: Pragmatic Guidance
7. International Guideline Recommendations for Insulin Initiation
8. International Guidelines Recommendations for Insulin Intensification
9. South Asian Guidelines on Insulin Therapy
10. Insulin Monograph: Review of Important Clinical Trials with Insulin
Section 4: Clinical Insulinology
11. Premixed Insulin in Clinical Practice
12. High-mix Insulins
13. Basal Insulin
14. Insulin with Glucagon-like Peptide-1 Receptor Agonist
Coformulations
15. Insulin Coformulations (Insulin Degludec/Insulin Aspart)
Section 5: Advances in Insulin
16. Noninjectable Insulin
17. Ultrafast-acting Insulin
18. Smart Insulin
19. Insulin Delivery Devices: From Then to Now
20. Insulin Pump Therapy in Diabetes
21. Newer Insulins on the Horizon
Section 6: Special Populations
22. Insulin in Type 1 Diabetes Mellitus
23. Insulin in Renal Impairment
24. Insulin in the Elderly
25. Insulin Therapy in Diabetes and Pregnancy
26. Insulin in Infants
Section 7: Special Situations
27. Insulin Use in Complicated Diabetic Infections
28. Nondiabetic Use of Insulin
29. Insulin in Diabetic Ketoacidosis and Other Acute
Hyperglycemic Conditions
30. Hypoglycemia Prone Patients
Section 8: Technique and Monitoring
31. Insulin Technique: Simply Fitter
32. Insulin Storage in Extreme Climates
33. Self-monitoring of Blood Glucose with Insulin Therapy
34. Modern Means of Glycemic Monitoring
35. Green Use of Insulin
36. Local Issues of Insulin Injections
Section 9: Psychosocial Aspects of Diabetes
37. Breaking the Psychological Resistance to Insulin
38. Myths about Insulin Therapy
Section 10: Public Health and Insulin
39. Insulin in the National List of Essential Medicines
40. Insulin: The Regulatory and the Public Health Aspects
41. Cost Containment and Insulin
42. Social Marketing of Insulin
Section 11: Challenges in Insulin Treatment in the Young
43. Overcoming Challenges of Insulin Therapy in Young
44. Creating Support Structure for Children on Insulin Therapy
45. Resource Creation for Insulin Availability
Section 12: Managing Insulin Therapy in Hospital
46. Transitioning Insulin from Intravenous to Subcutaneous
47. Managing Patients on Steroids
48. Perioperative Management Using Insulin Therapy
49. Managing Patients on Enteral and Parenteral Nutrition
50. Patients During Labor
